Marian Nakada
Venture Investments JJDC at Johnson & Johnson
Marian Nakada
Venture Investments JJDC at Johnson & Johnson
Cambridge, Massachusetts
Overview
Work Experience
Board Observer
2024 - Current
Vice President, Venture Investments JJDC
2013
Focuses on pharmaceutical venture investments on the East Coast, in support of Janssen R&D objectives. Works closely with Boston Innovation Center colleagues, Therapeutic Areas and cross-R&D Functional Areas.
Advisor
2019
Provide input to shape the themes, topics and speakers for the Convergence Forum
Member
2021
Board Observer
2021
Board Member
2020
Board Chair
2019 - 2020
Board Member
2013
Board Member
2016 - 2023
The NEVCA fosters a collaborative, inclusive, and prosperous innovation ecosystem on behalf of New England's VC industry. Operating across four pillars - Venture Community, Regional Brand, Workforce Development, and Public Policy - the association's initiatives impact the community at large: events connect founders, funders, and innovators; legislative advocacy promotes economic growth; programs bolster professional development across the venture landscape.
Board Member
2018 - 2023
Twentyeight-Seven Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), we can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.
Board Observer
2014 - 2021